<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>N‑Methyl‑Cyclazodone (NMC) • A Public Health Warning</title>
  
  <!-- SEO Meta Tags -->
  <meta name="description" content="A public health warning about the serious dangers of N-Methyl-Cyclazodone (NMC), an unregulated stimulant. Learn about the critical risk of sudden liver failure, dangerous drug interactions, and other health hazards." />
  <meta name="keywords" content="N-Methyl-Cyclazodone, NMC, cyclazodone, pemoline, stimulant, nootropic, research chemical, liver damage, hepatotoxicity, harm reduction, public health, NMC side effects, Is Cyclazodone safe, Pemoline alternatives, Nootropics liver damage" />
  <link rel="canonical" href="https://baftastic.github.io/nmc-analysis/" />

  <!-- Open Graph / Social Media Meta Tags -->
  <meta property="og:title" content="N‑Methyl‑Cyclazodone (NMC) • A Public Health Warning" />
  <meta property="og:description" content="A public health warning about the serious dangers of N-Methyl-Cyclazodone (NMC), an unregulated stimulant, focusing on the risk of liver failure." />
  <meta property="og:url" content="https://baftastic.github.io/nmc-analysis/" />
  <meta property="og:type" content="website" />

  <meta name="color-scheme" content="dark">
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">

  <style>
    /* * XFCE (Greybird-dark) Inspired Theme 
     * This theme uses a palette of charcoal grays and a classic accent blue
     * to create a professional, focused, and clean appearance.
     */
    :root {
      /* Base dark theme inspired by XFCE/Greybird */
      --bg-0: #2e3436; /* Dark charcoal main background */
      --bg-1: #353a3c; /* Slightly lighter background */
      --bg-card: #3c4143; /* Card and element background */
      --elev-1: 0 4px 12px rgba(0,0,0,0.3), 0 1px 3px rgba(0,0,0,0.2);

      /* Text colors for high contrast and readability */
      --txt-0: #eeeeec; /* Primary text (headings) */
      --txt-1: #d3d7cf; /* Secondary text (body) */
      --muted: #babdb6; /* Muted/metadata text */

      /* Classic XFCE blue accent palette */
      --accent: #729fcf;      /* Main accent blue for links, buttons */
      --accent-hover: #8cc0ff; /* Lighter blue for hover states */
      --warning: #f57900;     /* Orange for notices */
      --warning-bg: rgba(245, 121, 0, 0.1);
      --warning-border: rgba(245, 121, 0, 0.4);
      --danger: #cc0000;      /* Red for critical danger */
      --danger-bg: rgba(204, 0, 0, 0.1);
      --danger-border: rgba(204, 0, 0, 0.4);
      --success: #8ae234;     /* Green for success tags */
      --success-bg: rgba(138, 226, 52, 0.1);
      --success-border: rgba(138, 226, 52, 0.4);

      /* Borders and UI elements */
      --bd-strong: #555753;
      --bd-soft: #4a4f51;

      /* Code, selection, and focus styles */
      --code-bg: #2a2f30;
      --sel: rgba(114, 159, 207, 0.25);
      --focus: 0 0 0 3px rgba(114, 159, 207, 0.35);

      /* Typography */
      --font-sans: 'Inter', ui-sans-serif, system-ui, -apple-system, Segoe UI, Roboto, Helvetica, Arial, "Apple Color Emoji", "Segoe UI Emoji";
      --font-mono: ui-monospace, SFMono-Regular, Menlo, Monaco, Consolas, "Liberation Mono", "Courier New", monospace;
    }

    /* Basic Reset & Body Styling */
    * { box-sizing: border-box; }
    html, body {
      margin: 0;
      padding: 0;
      background-color: var(--bg-0);
      color: var(--txt-1);
      font-family: var(--font-sans);
      line-height: 1.65;
      -webkit-font-smoothing: antialiased;
      -moz-osx-font-smoothing: grayscale;
    }

    ::selection { background: var(--sel); }

    a {
      color: var(--accent);
      text-decoration: none;
      transition: color 0.15s ease;
    }
    a:hover { 
      color: var(--accent-hover);
      text-decoration: underline; 
    }

    /* Main Content Container */
    .container {
      max-width: 850px;
      margin: 0 auto;
      padding: 80px 20px 40px;
    }

    /* Sticky Header */
    .site-header {
      position: sticky;
      top: 0;
      z-index: 50;
      backdrop-filter: saturate(120%) blur(8px);
      -webkit-backdrop-filter: saturate(120%) blur(8px);
      background: rgba(46, 52, 54, 0.8);
      border-bottom: 1px solid var(--bd-soft);
    }
    .nav {
      max-width: 850px;
      margin: 0 auto;
      padding: 12px 20px;
      display: flex;
      align-items: center;
      gap: 12px;
    }
    .dot {
      width: 10px; height: 10px; border-radius: 50%;
      background-color: var(--accent);
      box-shadow: 0 0 10px rgba(114, 159, 207, 0.5);
    }
    .brand {
      font-weight: 600;
      font-size: 1.05rem;
      color: var(--txt-0);
    }
    .tag {
      margin-left: auto;
      font-size: 0.75rem;
      font-weight: 500;
      color: var(--txt-1);
      background: var(--bg-1);
      border: 1px solid var(--bd-soft);
      padding: 4px 10px;
      border-radius: 999px;
    }

    /* Typography */
    h1 {
      margin: 0 0 8px;
      font-size: 2.25rem;
      font-weight: 800;
      letter-spacing: -0.04em;
      color: var(--txt-0);
      line-height: 1.2;
    }
    .meta {
      color: var(--muted);
      font-size: 0.9rem;
    }
    h2 {
      margin: 0 0 12px;
      font-size: 1.5rem;
      font-weight: 700;
      color: var(--txt-0);
      letter-spacing: -0.02em;
    }
    h3 {
      margin: 16px 0 8px;
      font-size: 1.1rem;
      font-weight: 600;
      color: var(--txt-0);
    }
    p { margin: 8px 0 0; }
    ul {
      margin: 8px 0 0;
      padding-left: 20px;
    }
    li { margin: 6px 0; padding-left: 4px; }
    li::marker { color: var(--accent); }

    /* Cards & Sections */
    .card {
      background: var(--bg-card);
      border: 1px solid var(--bd-soft);
      border-radius: 12px;
      box-shadow: var(--elev-1);
      padding: 24px;
      margin: 24px 0;
      transition: border-color 0.2s ease, transform 0.2s ease;
    }
    .card:hover {
      border-color: var(--bd-strong);
    }

    /* Special Notice Card */
    .notice {
      background: var(--warning-bg);
      border: 1px solid var(--warning-border);
      color: var(--txt-1);
      padding: 24px;
      border-radius: 12px;
      box-shadow: var(--elev-1);
      margin: 32px 0;
    }
    .notice h2 { color: var(--warning); }
    .notice strong { color: var(--warning); font-weight: 600; }

    /* Danger Notice Card */
    .danger {
      background: var(--danger-bg);
      border: 1px solid var(--danger-border);
      color: var(--txt-1);
      padding: 24px;
      border-radius: 12px;
      box-shadow: var(--elev-1);
      margin: 24px 0;
    }
    .danger h2 { color: var(--danger); }
    .danger strong { color: var(--danger); font-weight: 600; }

    /* Accordion / Dropdown Styling */
    details {
      margin-top: 16px;
      background-color: rgba(0,0,0,0.15);
      border-radius: 8px;
      border: 1px solid var(--bd-soft);
    }
    summary {
      padding: 12px 16px;
      font-weight: 600;
      cursor: pointer;
      list-style: none;
      display: flex;
      align-items: center;
      justify-content: space-between;
      color: var(--txt-0);
    }
    summary::-webkit-details-marker { display: none; }
    summary:after {
      content: '›';
      font-size: 1.8rem;
      transform: rotate(90deg);
      transition: transform 0.2s ease;
      line-height: 1;
    }
    details[open] > summary:after {
      transform: rotate(-90deg);
    }
    .details-content {
      padding: 0 16px 16px;
      border-top: 1px solid var(--bd-soft);
      font-size: 0.95rem;
    }
    .details-content p { margin-top: 12px; }

    /* Action Buttons */
    .actions {
      display: flex;
      flex-wrap: wrap;
      gap: 12px;
      margin-top: 16px;
    }
    .btn {
      appearance: none;
      border: 1px solid var(--bd-strong);
      background-color: var(--bg-1);
      color: var(--txt-0);
      padding: 10px 18px;
      border-radius: 8px;
      font-weight: 600;
      transition: all .15s ease;
      box-shadow: 0 1px 2px rgba(0,0,0,0.2);
      cursor: pointer;
      text-decoration: none;
      display: inline-flex;
      align-items: center;
      gap: 8px;
    }
    .btn:hover {
      transform: translateY(-2px);
      box-shadow: 0 4px 8px rgba(0,0,0,0.3);
      background-color: var(--bg-card);
      border-color: var(--muted);
      text-decoration: none;
    }
    .btn.primary {
      background-color: var(--accent);
      border-color: var(--accent);
      color: #111;
    }
    .btn.primary:hover {
      background-color: var(--accent-hover);
      border-color: var(--accent-hover);
    }

    /* NEW: Infographic Section */
    .infographic-grid {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
      gap: 24px;
      margin-top: 16px;
    }
    .info-card {
      background: var(--bg-1);
      padding: 20px;
      border-radius: 8px;
      border: 1px solid var(--bd-soft);
      text-align: center;
    }
    .info-card .icon {
      margin: 0 auto 12px;
      width: 48px;
      height: 48px;
      color: var(--accent);
    }
    .info-card h3 {
      font-size: 1rem;
      margin: 0 0 8px;
      color: var(--txt-0);
    }
    .info-card p {
      font-size: 0.9rem;
      margin: 0;
      color: var(--txt-1);
    }
    .info-card .statistic {
      font-size: 1.75rem;
      font-weight: 700;
      color: var(--danger);
      line-height: 1.2;
    }

    /* Footer */
    .footer {
      margin-top: 32px;
      padding-top: 24px;
      border-top: 1px solid var(--bd-soft);
      color: var(--muted);
      font-size: 0.85rem;
    }
    .meta-grid {
      display: grid;
      grid-template-columns: auto 1fr;
      gap: 8px 16px;
      margin-bottom: 16px;
    }
    .meta-grid strong {
      color: var(--txt-1);
    }

    /* Responsive Adjustments */
    @media (max-width: 640px) {
      .container { padding-top: 72px; }
      h1 { font-size: 1.8rem; }
      h2 { font-size: 1.3rem; }
      .meta-grid { grid-template-columns: 1fr; }
    }

    /* Accessibility */
    :focus-visible { 
        outline: none; 
        box-shadow: var(--focus); 
        border-radius: 6px; 
    }
  </style>
</head>
<body>
  <header class="site-header" role="banner">
    <nav class="nav" aria-label="Primary">
      <span class="dot" aria-hidden="true"></span>
      <span class="brand">NMC Public Health Warning</span>
      <span class="tag">Harm Reduction</span>
    </nav>
  </header>

  <main class="container" role="main">
    <section aria-label="Introduction">
        <h1>N-Methyl-Cyclazodone (NMC): A Warning</h1>
        <p class="meta">
          Understanding the serious risks of this unregulated 'study drug', especially the danger of sudden liver failure.
        </p>
    </section>

    <section class="notice" aria-label="Critical safety notice">
      <h2>A Serious Warning About Your Liver</h2>
      <p>
        The most dangerous risk of using <strong>N‑Methyl‑Cyclazodone (NMC)</strong> is sudden, unpredictable, and potentially fatal liver failure. This is not a common side effect, but a rare catastrophe that can happen without warning. Because it belongs to a chemical family known for causing liver damage, this risk must be taken seriously.
      </p>
      <details>
        <summary>Why is the liver risk so high?</summary>
        <div class="details-content">
          <p>This warning is based on the history of <strong>Pemoline</strong>, a very similar drug once used for ADHD. Pemoline was banned after it was linked to at least 21 cases of liver failure, 13 of which resulted in death or required an emergency liver transplant. The liver damage was <strong>idiosyncratic</strong>, meaning it was unpredictable, not related to the dose, and could happen after months of seemingly safe use. Routine blood tests could not reliably predict who was at risk.</p>
        </div>
      </details>
    </section>

    <section class="danger" aria-label="Critical drug interaction warning">
      <h2>Danger: Interacts With Common Medications</h2>
      <p>
        Mixing NMC with other drugs can be extremely dangerous. A documented case showed that taking NMC while on a common antidepressant (like an SSRI) led to a life-threatening overdose. The combination can cause the body to be unable to process the drug, leading to toxic levels in your system. <strong>Do not mix NMC with other medications. Examples include Bupropion which inhibits CYP2D6 for 5-6 days because of the long half life of its metabolites, Grapefruit and related foods containing CYP3 inhibitors.</strong>
      </p>
       <details>
        <summary>How do these interactions happen?</summary>
        <div class="details-content">
          <p>Your body uses enzymes, particularly one called <strong>CYP2D6</strong>, to break down and remove drugs like NMC. Many common medications, including antidepressants like Fluoxetine (Prozac) and Bupropion (Wellbutrin), act as powerful inhibitors of this enzyme. When the enzyme is blocked, your body cannot clear NMC effectively. This causes the drug to build up to dangerously high, toxic levels, turning a normal dose into a life-threatening overdose.</p>
        </div>
      </details>
    </section>

    <!-- NEW: INFOGRAPHIC SECTION -->
    <section class="card" aria-labelledby="infographic-title">
      <h2 id="infographic-title">The Three Critical Dangers</h2>
      <div class="infographic-grid">
        <div class="info-card">
          <svg class="icon" xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10.29 3.86L1.82 18a2 2 0 0 0 1.71 3h16.94a2 2 0 0 0 1.71-3L13.71 3.86a2 2 0 0 0-3.42 0z"></path><line x1="12" y1="9" x2="12" y2="13"></line><line x1="12" y1="17" x2="12.01" y2="17"></line></svg>
          <h3>The Pemoline Precedent</h3>
          <p>NMC's chemical cousin, Pemoline, was banned after causing at least 21 cases of liver failure.</p>
          <p class="statistic">13</p>
          <p>resulted in death or required an emergency liver transplant.</p>
        </div>
        <div class="info-card">
          <svg class="icon" xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><circle cx="6" cy="6" r="3"></circle><circle cx="6" cy="18" r="3"></circle><line x1="20" y1="4" x2="8.12" y2="15.88"></line><line x1="14.47" y1="14.48" x2="20" y2="20"></line><line x1="8.12" y1="8.12" x2="12" y2="12"></line></svg>
          <h3>Dangerous Interactions</h3>
          <p>Common antidepressants (SSRIs, Wellbutrin) can block the enzyme that removes NMC from your body.</p>
          <p class="statistic">TOXIC</p>
          <p>This leads to a rapid, life-threatening buildup of the drug in your system.</p>
        </div>
        <div class="info-card">
          <svg class="icon" xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M12 22c5.523 0 10-4.477 10-10S17.523 2 12 2 2 6.477 2 12s4.477 10 10 10z"></path><line x1="12" y1="8" x2="12" y2="12"></line><line x1="12" y1="16" x2="12.01" y2="16"></line></svg>
          <h3>Unpredictable Risk</h3>
          <p>Liver failure is not dose-dependent. It's a rare but catastrophic event that can happen to anyone at any time.</p>
          <p class="statistic">NO</p>
          <p>There is no known "safe" dose or way to predict who is vulnerable.</p>
        </div>
      </div>
    </section>

    <!-- NEW: FAQ SECTION -->
    <section class="card" aria-labelledby="faq-title">
      <h2 id="faq-title">Frequently Asked Questions</h2>
      <details>
        <summary>Is there a safe dose of NMC?</summary>
        <div class="details-content">
          <p><strong>No.</strong> The most severe risk, liver failure, is 'idiosyncratic,' meaning it's unpredictable and not related to the dose. It can happen to a susceptible person at any dose, at any time. There is no known way to determine who is susceptible.</p>
        </div>
      </details>
      <details>
        <summary>Can I just monitor my liver with blood tests?</summary>
        <div class="details-content">
          <p><strong>This is not a reliable strategy.</strong> With the related drug Pemoline, liver failure sometimes occurred so rapidly that it happened between routine tests. In some of the fatal cases, patients had shown normal liver enzyme levels on previous tests before suddenly developing catastrophic liver failure.</p>
        </div>
      </details>
    </section>

    <section class="card" aria-labelledby="exec">
      <h2 id="exec">Key Dangers at a Glance</h2>
      <ul>
        <li><strong>What it is:</strong> An unregulated stimulant, chemically related to other drugs in a family known for causing severe side effects.</li>
        <li><strong>How it's used:</strong> Often sold online as a 'research chemical' and used as a so-called 'smart drug' or for self-treating ADHD.</li>
        <li><strong>The Biggest Danger:</strong> A risk of sudden, severe, and irreversible liver failure. A related drug was banned because it caused deaths and required liver transplants.</li>
        <li><strong>Overdose Effects:</strong> A documented overdose caused life-threatening effects, including dangerous heart problems, severe muscle breakdown, and brain and nerve damage.</li>
        <li><strong>Legality vs. Safety:</strong> The legal status is complex and varies. However, the severe, life-threatening health risks make any legal debate irrelevant. This substance should be avoided for safety reasons alone.</li>
      </ul>
    </section>

    <section class="card" aria-labelledby="long-term-risks">
      <h2 id="long-term-risks">Long-Term Risks: Dependence and Withdrawal</h2>
      <p>
        Beyond the immediate dangers, regular use of NMC carries a high risk of psychological dependence. Because it is a potent stimulant, your brain can adapt to its presence, leading to addiction. Stopping the drug after long-term use can cause a severe "crash," with symptoms like extreme fatigue, inability to feel pleasure, and deep depression. This makes it very difficult to quit.
      </p>
      <details>
        <summary>Learn more about dependence</summary>
        <div class="details-content">
          <p>Stimulants like NMC increase dopamine in the brain, which is linked to motivation and reward. With long-term use, the brain reduces its own dopamine production to compensate. This leads to <strong>tolerance</strong> (needing more of the drug for the same effect) and <strong>withdrawal</strong> when the drug is stopped. The withdrawal syndrome is characterized by a deep lack of motivation and pleasure (anhedonia), which creates a powerful craving to use the drug again.</p>
        </div>
      </details>
    </section>

    <section class="card" aria-labelledby="identifiers">
        <h2 id="identifiers">Chemical Information</h2>
        <div class="meta-grid">
            <strong>Common Names:</strong> <span>N‑Methyl‑Cyclazodone, NMC</span>
            <strong>CAS Number:</strong> <span>14461‑92‑8</span>
            <strong>Chemical Class:</strong> <span>5‑phenyl‑4‑oxazolidinone stimulant</span>
        </div>
    </section>

    <section class="card" aria-labelledby="download">
      <h2 id="download">Read the Full Scientific Report Generated by Gemini,</h2>
      <p> Mistakes can happen but holistically its 99% correct and thats what matters. For a deep dive into the science, including detailed case studies and chemical analysis, you can download the complete PDF report. And if you share it to others, maybe livers and lifes will be saved.</p>
      <div class="actions">
        <a class="btn primary" href="./N-Methyl-Cyclazodone-Human-Use-Analysis.pdf" role="button" aria-label="Download PDF">
          <svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2.5" stroke-linecap="round" stroke-linejoin="round"><path d="M21 15v4a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2v-4"></path><polyline points="7 10 12 15 17 10"></polyline><line x1="12" y1="15" x2="12" y2="3"></line></svg>
          Download PDF
        </a>
        <a class="btn" href="./N-Methyl-Cyclazodone-Human-Use-Analysis.pdf" target="_blank" rel="noopener" role="button" aria-label="View PDF in browser">
          <svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2.5" stroke-linecap="round" stroke-linejoin="round"><path d="M1 12s4-8 11-8 11 8 11 8-4 8-11 8-11-8-11-8z"></path><circle cx="12" cy="12" r="3"></circle></svg>
          View in Browser
        </a>
      </div>
    </section>

    <footer class="footer" role="contentinfo" aria-label="Document metadata">
      <div class="meta-grid">
        <strong>Source:</strong> <span>Based on the report "N‑Methyl‑Cyclazodone: A Pharmacological and Toxicological Assessment"</span>
        <strong>Contact:</strong> <span><a href="mailto:pharmacology@catom.dev">pharmacology@catom.dev</a></span>
      </div>
      <p class="muted">
        This page is for public health awareness and harm reduction. It is not medical or legal advice. The software and associated documentation files are provided under the MIT License.
      </p>
    </footer>
  </main>
</body>
</html>
